SLC7A11 and hepatocellular carcinoma: Conversely, compared with normal liver, the expression of SLC7A11 was upregulated to 3.343‐fold (p = 6.18 × 10−6) (Figure 2D), 1.943‐fold (p = 1.58 × 10−4) (Figure 2E) and 1.494‐fold (p = 1.47 × 10−18) (Figure 2F) in HCC patients, respectively.